Novavax Inc (NVAX) is a publicly traded Healthcare sector company. As of May 20, 2026, NVAX trades at $9.33 with a market cap of $1.47B and a P/E ratio of -17.12. NVAX moved +4.33% today. Year to date, NVAX is +24.82%; over the trailing twelve months it is +14.99%. Its 52-week range spans $5.01 to $15.22. Analyst consensus is neutral with an average price target of $11.60. Rallies surfaces NVAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own NVAX include Coatue Management, Farallon Capital, and Sculptor Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Novavax Inc.
| Metric | Value |
|---|---|
| Price | $9.33 |
| Market Cap | $1.47B |
| P/E Ratio | -17.12 |
| EPS | $-0.54 |
| Dividend Yield | 0.11% |
| 52-Week High | $15.22 |
| 52-Week Low | $5.01 |
| Volume | 4.37M |
| Avg Volume | 0 |
| Revenue (TTM) | $596.34M |
| Net Income | $-87.83M |
| Gross Margin | 84.97% |
5 analysts cover NVAX: 0 strong buy, 2 buy, 1 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.60.